Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Daniel Prieto-Alhambra has been awarded the 'Special ISPE award for contributions to public health associated with the COVID-19 pandemic.'

Dani receiving his award from ISPE
Dani (second from right) with his ISPE award recognising his contribution to COVID-19 research

The award was presented at the 38th International Conference on Pharmacoepidemiology, which took place in Copenhagen, in recognition of Dani's demonstrable impact on public health related to the COVID-19 pandemic through his work in Pharmacoepidemiology.

Daniel is the Professor of Pharmaco- and Device Epidemiology and Section Head for Health Data Sciences at the Botnar Research Centre, NDORMS, University of Oxford.

As a member of the European Health Data & Evidence Network (EHDEN) and the Observational Health Data Sciences and Informatics (OHDSI), Dani has studied the impacts and effects of COVID-19 throughout the pandemic to better inform the global response.

Projects included:

  • Projects exploring the risks and efficacy of the COVID-19 vaccines, including the impact on neurological disorders;
  • An international study to understand the characteristics of patients suffering from COVID-19 in greater detail;
  • Research to understand the safety profile and risks of Hydroxychloroquine, that was considered a potential COVID-19 treatment;
  • And hosting a COVID-19 virtual study-a-thon to inform healthcare decision-making in response to the global pandemic.

Commenting on the award Daniel said: "All senior awards recognise the work of many, not one individual. This one in particular acknowledges the work of my team at the Botnar Research Centre (University of Oxford), Erasmus MC Rotterdam, and colleagues in the EHDEN and OHDSI communities who went the extra mile for months. We rallied to generate actionable evidence on the impact of COVID-19, and for the monitoring of COVID vaccine safety."

Similar stories

MRC funding awarded to Kennedy researchers

Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.

Junqing Xie awarded by the International Society for Pharmacoepidemiology

Congratulations to Junqing (Frank) Xie who has been awarded the Stanley A. Edlavitch Award from The International Society for Pharmacoepidemiology (ISPE).

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination

Researchers at NDORMS have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.